| Current Price | $6.13 | Mkt Cap | $488.2M |
|---|---|---|---|
| Open | $6.45 | P/E Ratio | 0.00 |
| Prev. Close | $6.13 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $5.96 - $6.48 | Volume | 5,427,264 |
| 52-Wk Range | $2.87 - $25.39 | Avg. Daily Vol. | 9,769,986 |
| Current Price | $6.13 | Mkt Cap | $488.2M |
|---|---|---|---|
| Open | $6.45 | P/E Ratio | 0.00 |
| Prev. Close | $6.13 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $5.96 - $6.48 | Volume | 5,427,264 |
| 52-Wk Range | $2.87 - $25.39 | Avg. Daily Vol. | 9,769,986 |
The best Bull and Bear pitches based on recency and number of recommendations.
From Fidelity or Zacks December 2021:Revenue Growth (Last 5 Years) = 77.9%Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 17.7%Price/Sales (TTM) = 14.2Re-establishing this position at a lower price.
Weak pipeline, continued difficulty with commercialization, recently lost 100% of its C-suite, ongoing litigation, and more.
Read the most recent pitches from players about BLUE.
Recs
Car12703
(< 20)
Submitted: 12/20/2021 10:25:57 AM :
Start Price:
$8.32
NASDAQ:BLUE Score:
-7.22
From Fidelity or Zacks December 2021:
Revenue Growth (Last 5 Years) = 77.9%
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 17.7%
Price/Sales (TTM) = 14.2
Re-establishing this position at a lower price.
Recs
Ficktory
(< 20)
Submitted: 12/13/2021 2:27:25 PM :
Start Price:
$9.36
NASDAQ:BLUE Score:
-12.88
Gene therapies will be a huge growth sector in health care in the next decade.
Recs
TMFacarchidi
(< 20)
Submitted: 12/1/2021 10:19:45 AM :
Start Price:
$10.58
NASDAQ:BLUE Score:
+21.29
Weak pipeline, continued difficulty with commercialization, recently lost 100% of its C-suite, ongoing litigation, and more.
Find the members with the highest scoring picks in BLUE.
DoubleBagel (< 20) Score: +669.10
The Score Leader is the player with the highest score across all their picks in BLUE.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| secohen11 | < 20 | 7/2/2013 |
|
1Y | $26.20 | -76.60% | +127.52% | +204.12 | 0 Comment | |
| saab93boi | 21.17 | 6/19/2013 |
|
5Y | $25.68 | -76.12% | +122.97% | +199.09 | 0 Comment | |
| rwpaules | 89.57 | 6/19/2013 |
|
3Y | $25.09 | -75.57% | +121.53% | +197.09 | 0 Comment | |
| biotechf | 34.23 | 1/22/2016 |
|
3M | $44.44 | -86.21% | +93.63% | +179.83 | 0 Comment | |
| MotleyFolJohn | < 20 | 2/2/2015 |
|
1Y | $93.98 | -93.48% | +83.58% | +177.06 | 1 Comment | |
|
CommodityBuyer | < 20 | 7/10/2015 |
|
5Y | $160.69 | -96.19% | +76.75% | +172.94 | 0 Comment |
| pro64grammer | 28.03 | 12/9/2014 |
|
5Y | $79.58 | -92.30% | +79.09% | +171.39 | 0 Comment | |
| 3rdChanceTom | 85.82 | 3/11/2016 |
|
5Y | $45.77 | -86.61% | +82.14% | +168.75 | 0 Comment | |
| GreenAB | 29.31 | 3/5/2015 |
|
NS | $106.20 | -94.23% | +73.94% | +168.17 | 0 Comment | |
| coptermech66 | < 20 | 10/29/2015 |
|
3Y | $79.54 | -92.29% | +75.56% | +167.85 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
